The Business Times

Mirxes

Companies & Markets

A*Star biotech spin-off Mirxes trims losses to US$28.4 million as top line grows

Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment 

Mirxes says it expects its addition to the index will significantly increase the company’s visibility and trading liquidity.
Companies & Markets

Singapore-headquartered Mirxes to join Alibaba, Tencent on Hang Seng Composite Index

Biotech firm will be part of Hong Kong market benchmark from Sep 8

Mirxes intends to use about half of the net proceeds for research and development, regulatory filings and manufacturing and commercialisation of Gastroclear.
Global Enterprise

Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion 

Shares are expected to start trading on May 23

Mirxes is still considering a secondary listing in Singapore, says CEO Dr Zhou Lihan.
Startups

‘A fighting chance’: Mirxes on why it chose Hong Kong over Singapore for its IPO

Chief executive Dr Zhou Lihan says Hong Kong offered a better valuation and a more savvy investor pool

Mirxes co-founder Zhou Lihan says the company hopes to tap Hong Kong and China's healthcare and biotech investor base.
Global Enterprise

Singapore biotech Mirxes files for Hong Kong IPO after raising US$50 million

CANCER diagnostics company Mirxes has applied to Hong Kong’s stock exchange for an initial public offering (IPO), potentially becoming the first company based outside of China and Hong Kong to list un...

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More